VivoSeq
Other

Endometrial

0

Pipeline Programs↗

8

Active Trials↗

4

Companies Involved↗

Endometrial is an early-stage landscape with 0 programs across 4 companies. The most active players are Bayer, Solvay Pharmaceuticals, AstraZeneca.

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

77/100

Attrition Rate

13/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Bayer logo

Bayer

0 programs

PreclinicalS

Solvay Pharmaceuticals

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalJ

Juniper Pharmaceuticals, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

52

clinical trials

Completed24 · 46%
Unknown status13 · 25%
Terminated6 · 12%
Recruiting5 · 10%
Active, not recruiting2 · 4%
Withdrawn1 · 2%
Other1 · 2%

Clinical Trials

Trial Activity

52 trials

Methoxyflurane for IUD Insertion and Endometrial Biopsy
Recruiting·MMount Sinai Hospital, Canada·N/A·NCT07046572·174 enrolled
Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study
Recruiting·TTata Memorial Centre·N/A·NCT05857631·90 enrolled
Effects of Intrauterine Administration of Autologous PBMC on the Endometrial Cells Populations
Recruiting·NNadezhda Women's Health Hospital·N/A·NCT05421364·300 enrolled
Effects of Intrauterine Administration of Autologous PBMC Modulated With IFNt on Endometrial Cell Populations
Recruiting·NNadezhda Women's Health Hospital·N/A·NCT05775211·300 enrolled
Endometrial Biopsy in Progestin Contraceptive Users
Recruiting·OOregon Health and Science University·Phase 1·NCT05760144·52 enrolled
Subendometrial Injection Versus Intrauterine Infusion of Platelet Rich Plasma for Women With Recurrent Implantation Failure
Active, not recruiting·MMinia University·N/A·NCT07306871·180 enrolled
mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian
Active, not recruiting·MM.D. Anderson Cancer Center·Phase 1·NCT02208375·159 enrolled
Postmenopausal Asymptomatic Women With Thick Endometrium: Hysteroscopic and Histopathological Report
Not yet recruiting·SSohag University·N/A·NCT07695077·120 enrolled
Hysteroscopic Injections of Autologous Endometrial Cells and Platelet-rich Plasma in Patients With Thin Endometrium
Completed·Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare·Phase 1·NCT05455151·115 enrolled
Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success
Completed·—·N/A·NCT02381821·82 enrolled
1% Lidocaine Paracervical Block for Endometrial Biopsy
Completed·MMount Sinai Hospital, Canada·N/A·NCT06546254·96 enrolled
Transdermal Contraceptive Patch - Endometrial Effects Study
Completed·Bayer logoBayer·Phase 2·NCT00896571·92 enrolled
The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation
Completed·UUniversity of Palermo·Phase 4·NCT06316206·80 enrolled
Optimizing Analgesia for Endometrial Biopsy
Completed·GGaziosmanpasa Research and Education Hospital·Phase 4·NCT06540599·197 enrolled
HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients
Completed·RReproductive & Genetic Hospital of CITIC-Xiangya·N/A·NCT03578172·186 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)